Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash Flows From Operating Activities
Net Loss	$ (4,698)	$ (3,334)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	368	149
Stock-based compensation	971	529
Deferred tax liability	(6)	0
Changes in operating assets and (liabilities):
Accounts receivable	(2,084)	95
Inventories	(104)	(1)
Prepaid expenses and other current assets	(45)	(179)
Other assets	0	(93)
Accrued expenses	572	(309)
Accounts payable	1,238	(2,338)
Accounts payable - related parties	(2)	0
Other current liabilities	(22)	0
Accrued income taxes	0	(25,325)
Total Adjustments	886	(27,472)
Net Cash Used in Operating Activities	(3,812)	(30,806)
Cash Flows From Investing Activities
Investment in limited partnership venture capital fund	(500)	0
Cash acquired through merger with Converted Organics	0	63
Proceeds of notes receivable acquired through merger with Converted Organics	0	517
Purchases of property and equipment	(20)	(20)
Net Cash (Used in) Provided by Investing Activities	(520)	560
Cash Flows From Financing Activities
Proceeds from exercise of stock options	124	0
Repayment of loan from former parent	0	(33,943)
Repurchase of common stock	0	(204)
Net Cash Provided by (Used in) Financing Activities	124	(34,147)
Net Decrease in Cash and Cash Equivalents	(4,208)	(64,393)
Cash and Cash Equivalents - Beginning	24,598	91,545
Cash and Cash Equivalents - Ending	20,390	27,152
Cash paid during the quarter for:
Income Taxes	3	25,325
Non-cash Investing and Financing activities:
Dividend of investments to parent	$ 0	$ 12,784